Silvio Veronese

18.4k total citations · 4 hit papers
91 papers, 5.4k citations indexed

About

Silvio Veronese is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Silvio Veronese has authored 91 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 32 papers in Pulmonary and Respiratory Medicine and 24 papers in Molecular Biology. Recurrent topics in Silvio Veronese's work include Colorectal Cancer Treatments and Studies (22 papers), Lung Cancer Treatments and Mutations (18 papers) and Chronic Lymphocytic Leukemia Research (13 papers). Silvio Veronese is often cited by papers focused on Colorectal Cancer Treatments and Studies (22 papers), Lung Cancer Treatments and Mutations (18 papers) and Chronic Lymphocytic Leukemia Research (13 papers). Silvio Veronese collaborates with scholars based in Italy, United States and United Kingdom. Silvio Veronese's co-authors include Salvatore Siena, Andrea Sartore‐Bianchi, Alberto Bardelli, Federica Di Nicolantonio, Mauro Moroni, Silvia Benvenuti, Marcello Gambacorta, Giovanna Marrapese, Michele Nichelatti and Carlo Zanon and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Silvio Veronese

88 papers receiving 5.3k citations

Hit Papers

Gene copy number for epidermal growth factor receptor (EG... 2005 2026 2012 2019 2005 2007 2009 2013 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study
    2005 771 citations Mauro Moroni, Silvio Veronese et al. profile →
  2. Oncogenic Activation of the RAS/RAF Signaling Pathway Impairs the Response of Metastatic Colorectal Cancers to Anti–Epidermal Growth Factor Receptor Antibody Therapies
    2007 672 citations Andrea Sartore‐Bianchi, Federica Di Nicolantonio et al. Cancer Research profile →
  3. PIK3CA Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodies
    2009 601 citations Andrea Sartore‐Bianchi, Miriam Martini et al. Cancer Research profile →
  4. Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial
    2013 376 citations Silvio Veronese, Calogero Lauricella et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silvio Veronese Italy 31 3.6k 2.0k 1.6k 1.5k 1.1k 91 5.4k
Francesca Molinari Switzerland 26 3.1k 0.9× 1.5k 0.8× 1.5k 0.9× 1.5k 1.0× 1.1k 1.0× 55 4.7k
Milo Frattini Italy 37 4.9k 1.3× 2.5k 1.2× 2.6k 1.7× 2.3k 1.6× 1.9k 1.7× 109 7.6k
Allen Lee Cohn United States 38 4.7k 1.3× 2.4k 1.2× 1.5k 1.0× 1.0k 0.7× 1.3k 1.1× 159 6.9k
Johannes Nippgen Germany 15 3.2k 0.9× 1.4k 0.7× 782 0.5× 922 0.6× 629 0.6× 27 4.3k
Rona Yaeger United States 38 4.0k 1.1× 1.4k 0.7× 2.5k 1.6× 2.0k 1.3× 1.6k 1.4× 201 6.1k
Youngchul Song United States 13 3.0k 0.8× 2.7k 1.3× 3.0k 1.9× 577 0.4× 908 0.8× 18 5.5k
Fiamma Buttitta Italy 45 3.5k 1.0× 2.9k 1.5× 3.6k 2.3× 702 0.5× 2.4k 2.1× 102 7.1k
Samuel J. Klempner United States 39 3.3k 0.9× 2.2k 1.1× 1.7k 1.1× 1.1k 0.7× 1.3k 1.2× 197 5.4k
Angela Zubel Germany 21 4.8k 1.3× 2.0k 1.0× 1.4k 0.9× 1.4k 0.9× 815 0.7× 34 5.8k
David S. Rickman United States 34 1.4k 0.4× 1.6k 0.8× 2.8k 1.8× 855 0.6× 1.6k 1.4× 63 5.6k

Countries citing papers authored by Silvio Veronese

Since Specialization
Citations

This map shows the geographic impact of Silvio Veronese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvio Veronese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvio Veronese more than expected).

Fields of papers citing papers by Silvio Veronese

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvio Veronese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvio Veronese. The network helps show where Silvio Veronese may publish in the future.

Co-authorship network of co-authors of Silvio Veronese

This figure shows the co-authorship network connecting the top 25 collaborators of Silvio Veronese. A scholar is included among the top collaborators of Silvio Veronese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvio Veronese. Silvio Veronese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marando, Alessandro, Calogero Lauricella, Valentina Motta, et al.. (2024). SMARCB1/INI1-deficient undifferentiated tumour of the thorax: a case report and review of the literature. Pathologica. 116(3). 163–169. 1 indexed citations
2.
Marando, Alessandro, Emanuele Valtorta, Calogero Lauricella, et al.. (2024). Biphenotypic lung carcinoma with coexpression of TTF-1 and ΔNP63/P40 within most of the same individual cells: a further case confirming poor prognosis and a review of literature. Pathologica. 116(1). 13–21. 1 indexed citations
3.
Pizzutilo, Elio Gregory, Valentina Motta, Calogero Lauricella, et al.. (2023). Repotrectinib Overcomes F2004V Resistance Mutation in ROS1-Rearranged NSCLC: A Case Report. JTO Clinical and Research Reports. 4(11). 100555–100555. 5 indexed citations
4.
Lauricella, Calogero, et al.. (2022). Acute Promyelocytic Leukemia with del(6)(p22) and Atypical bcr2 PML::RARA Fusion Transcript: A Case Report. Acta Haematologica. 146(1). 61–67. 2 indexed citations
5.
Marchetti, Antonio, Mattia Barbareschi, Massimo Barberis, et al.. (2021). Real-World Data on NGS Diagnostics: a survey from the Italian Society of Pathology (SIAPeC) NGS Network. Pathologica. 113(4). 262–271. 12 indexed citations
6.
Ammirati, Enrico, Marisa Varrenti, Giacomo Veronese, et al.. (2021). Prevalence and outcome of patients with acute myocarditis and positive viral search on nasopharyngeal swab. European Journal of Heart Failure. 23(7). 1242–1245. 12 indexed citations
7.
Veronese, Giacomo, Enrico Ammirati, Rossella Baldan, et al.. (2018). Single‐center outbreak of Pneumocystis jirovecii pneumonia in heart transplant recipients. Transplant Infectious Disease. 20(3). e12880–e12880. 14 indexed citations
8.
Frustaci, Anna Maria, Chiara Rusconi, Silvio Veronese, et al.. (2015). Bing Neel Syndrome in a Previously Untreated Patient With Waldenström's Macroglobulinemia: Contribution of MYD88 L265P Mutation on Cerebrospinal Fluid. Clinical Lymphoma Myeloma & Leukemia. 16(1). e7–e9. 7 indexed citations
9.
Cesare, Michelandrea De, Calogero Lauricella, Silvio Veronese, et al.. (2013). Synergistic Antitumor Activity of Cetuximab and Namitecan in Human Squamous Cell Carcinoma Models Relies on Cooperative Inhibition of EGFR Expression and Depends on High EGFR Gene Copy Number. Clinical Cancer Research. 20(4). 995–1006. 6 indexed citations
10.
Ricci, Francesca, Alessandra Tedeschi, Chiara Colombo, et al.. (2013). Should a Positive Direct Antiglobulin Test Be Considered a Prognostic Predictor in Chronic Lymphocytic Leukemia?. Clinical Lymphoma Myeloma & Leukemia. 13(4). 441–446. 10 indexed citations
11.
Marziliano, Nicola, Francesco Orsini, Valentina Motta, et al.. (2012). A quantitative-PCR protocol rapidly detects αGAL deletions/duplications in patients with Anderson–Fabry disease. Molecular Genetics and Metabolism. 105(4). 687–689. 5 indexed citations
12.
Sartore‐Bianchi, Andrea, Steffen Fieuws, Silvio Veronese, et al.. (2011). Standardisation of EGFR FISH in colorectal cancer: results of an international interlaboratory reproducibility ring study. Journal of Clinical Pathology. 65(3). 218–223. 30 indexed citations
13.
Sartore‐Bianchi, Andrea, Miriam Martini, Francesca Molinari, et al.. (2009). PIK3CA Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodies. Cancer Research. 69(5). 1851–1857. 601 indexed citations breakdown →
14.
Sartore‐Bianchi, Andrea, Mauro Moroni, Silvio Veronese, et al.. (2007). Epidermal Growth Factor Receptor Gene Copy Number and Clinical Outcome of Metastatic Colorectal Cancer Treated With Panitumumab. Journal of Clinical Oncology. 25(22). 3238–3245. 264 indexed citations
15.
Montillo, Marco, Alessandra Tedeschi, Sara Miqueleiz, et al.. (2006). Alemtuzumab As Consolidation After a Response to Fludarabine Is Effective in Purging Residual Disease in Patients With Chronic Lymphocytic Leukemia. Journal of Clinical Oncology. 24(15). 2337–2342. 111 indexed citations
16.
Moroni, Mauro, Silvio Veronese, Roberta Schiavo, et al.. (2001). Epidermal growth factor receptor expression and activation in nonseminomatous germ cell tumors.. PubMed. 7(9). 2770–5. 42 indexed citations
17.
Mauri, Francesco, Orazio Caffo, Silvio Veronese, et al.. (1998). Tissue carcinoembryonic antigen and oestrogen receptor status in breast carcinoma: an immunohistochemical study of clinical outcome in a series of 252 patients with long-term follow-up. British Journal of Cancer. 77(10). 1661–1668. 15 indexed citations
18.
Barberis, Massimo, et al.. (1997). Calretinin. Acta Cytologica. 41(6). 1757–1761. 77 indexed citations
19.
Barbareschi, Mattia, Orazio Caffo, Silvio Veronese, et al.. (1996). Bcl-2 and p53 expression in node-negative breast carcinoma: A study with long-term follow-up. Human Pathology. 27(11). 1149–1155. 92 indexed citations
20.
Barberis, Massimo, et al.. (1995). Immunocytochemical Detection of Progesterone Receptors. CHEST Journal. 107(3). 869–872. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesca Molinari Breakdown of academic impact, for papers by Milo Frattini Breakdown of academic impact, for papers by Allen Lee Cohn Breakdown of academic impact, for papers by Johannes Nippgen Breakdown of academic impact, for papers by Rona Yaeger Breakdown of academic impact, for papers by Youngchul Song Breakdown of academic impact, for papers by Fiamma Buttitta Breakdown of academic impact, for papers by Samuel J. Klempner Breakdown of academic impact, for papers by Angela Zubel Breakdown of academic impact, for papers by David S. Rickman
Rankless by CCL
2026